UCB SA (UCB.BR) Fundamental Analysis & Valuation

EBR:UCB • BE0003739530

Current stock price

249.75 EUR
-1.55 (-0.62%)
Last:

This UCB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UCB.BR Profitability Analysis

1.1 Basic Checks

  • UCB had positive earnings in the past year.
  • UCB had a positive operating cash flow in the past year.
  • Each year in the past 5 years UCB has been profitable.
  • Each year in the past 5 years UCB had a positive operating cash flow.
UCB.BR Yearly Net Income VS EBIT VS OCF VS FCFUCB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of UCB (8.58%) is better than 66.67% of its industry peers.
  • UCB has a better Return On Equity (14.34%) than 60.78% of its industry peers.
  • UCB's Return On Invested Capital of 12.94% is fine compared to the rest of the industry. UCB outperforms 64.71% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for UCB is significantly below the industry average of 14.61%.
  • The 3 year average ROIC (7.24%) for UCB is below the current ROIC(12.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROIC 12.94%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)7.24%
ROIC(5y)7.33%
UCB.BR Yearly ROA, ROE, ROICUCB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • UCB's Profit Margin of 20.13% is fine compared to the rest of the industry. UCB outperforms 78.43% of its industry peers.
  • UCB's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 25.98%, UCB is doing good in the industry, outperforming 68.63% of the companies in the same industry.
  • UCB's Operating Margin has improved in the last couple of years.
  • The Gross Margin of UCB (74.29%) is better than 70.59% of its industry peers.
  • UCB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
UCB.BR Yearly Profit, Operating, Gross MarginsUCB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. UCB.BR Health Analysis

2.1 Basic Checks

  • UCB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, UCB has about the same amount of shares outstanding.
  • The number of shares outstanding for UCB has been increased compared to 5 years ago.
  • Compared to 1 year ago, UCB has an improved debt to assets ratio.
UCB.BR Yearly Shares OutstandingUCB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
UCB.BR Yearly Total Debt VS Total AssetsUCB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • UCB has an Altman-Z score of 5.61. This indicates that UCB is financially healthy and has little risk of bankruptcy at the moment.
  • UCB has a Altman-Z score of 5.61. This is amongst the best in the industry. UCB outperforms 80.39% of its industry peers.
  • The Debt to FCF ratio of UCB is 1.22, which is an excellent value as it means it would take UCB, only 1.22 years of fcf income to pay off all of its debts.
  • UCB has a Debt to FCF ratio of 1.22. This is amongst the best in the industry. UCB outperforms 90.20% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that UCB is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.20, UCB is doing good in the industry, outperforming 74.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Altman-Z 5.61
ROIC/WACC1.61
WACC8.03%
UCB.BR Yearly LT Debt VS Equity VS FCFUCB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that UCB should not have too much problems paying its short term obligations.
  • UCB has a Current ratio (1.38) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.04 indicates that UCB should not have too much problems paying its short term obligations.
  • The Quick ratio of UCB (1.04) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.04
UCB.BR Yearly Current Assets VS Current LiabilitesUCB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. UCB.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 100.60% over the past year.
  • Measured over the past years, UCB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.26% on average per year.
  • Looking at the last year, UCB shows a very strong growth in Revenue. The Revenue has grown by 25.83%.
  • Measured over the past years, UCB shows a small growth in Revenue. The Revenue has been growing by 7.68% on average per year.
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.75% on average over the next years. This is quite good.
  • Based on estimates for the next years, UCB will show a quite strong growth in Revenue. The Revenue will grow by 10.92% on average per year.
EPS Next Y2.96%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
EPS Next 5Y16.75%
Revenue Next Year11.84%
Revenue Next 2Y12.38%
Revenue Next 3Y12.24%
Revenue Next 5Y10.92%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UCB.BR Yearly Revenue VS EstimatesUCB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
UCB.BR Yearly EPS VS EstimatesUCB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. UCB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.00 indicates a quite expensive valuation of UCB.
  • UCB's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, UCB is valued at the same level.
  • The Price/Forward Earnings ratio is 24.28, which indicates a rather expensive current valuation of UCB.
  • UCB's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.51. UCB is around the same levels.
Industry RankSector Rank
PE 25
Fwd PE 24.28
UCB.BR Price Earnings VS Forward Price EarningsUCB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • UCB's Enterprise Value to EBITDA is on the same level as the industry average.
  • UCB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.37
EV/EBITDA 18.29
UCB.BR Per share dataUCB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of UCB may justify a higher PE ratio.
  • UCB's earnings are expected to grow with 17.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.45
PEG (5Y)1.89
EPS Next 2Y15.35%
EPS Next 3Y17.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. UCB.BR Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.39%, UCB is not a good candidate for dividend investing.
  • UCB's Dividend Yield is comparable with the industry average which is at 1.90.
  • With a Dividend Yield of 0.39, UCB pays less dividend than the S&P500 average, which is at 1.90.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

  • The dividend of UCB has a limited annual growth rate of 2.20%.
Dividend Growth(5Y)2.2%
Div Incr Years6
Div Non Decr Years6
UCB.BR Yearly Dividends per shareUCB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • 16.94% of the earnings are spent on dividend by UCB. This is a low number and sustainable payout ratio.
  • The dividend of UCB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP16.94%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
UCB.BR Yearly Income VS Free CF VS DividendUCB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UCB.BR Dividend Payout.UCB.BR Dividend Payout, showing the Payout Ratio.UCB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UCB.BR Fundamentals: All Metrics, Ratios and Statistics

UCB SA

EBR:UCB (3/27/2026, 1:25:07 PM)

249.75

-1.55 (-0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)07-21
Inst Owners40.45%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.58B
Revenue(TTM)7.74B
Net Income(TTM)1.56B
Analysts75.56
Price Target282.94 (13.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend1.39
Dividend Growth(5Y)2.2%
DP16.94%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.63%
PT rev (3m)10.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.02%
EPS NY rev (3m)1.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)3.27%
Valuation
Industry RankSector Rank
PE 25
Fwd PE 24.28
P/S 6.28
P/FCF 26.37
P/OCF 21.2
P/B 4.47
P/tB 20.86
EV/EBITDA 18.29
EPS(TTM)9.99
EY4%
EPS(NY)10.29
Fwd EY4.12%
FCF(TTM)9.47
FCFY3.79%
OCF(TTM)11.78
OCFY4.72%
SpS39.8
BVpS55.87
TBVpS11.97
PEG (NY)8.45
PEG (5Y)1.89
Graham Number112.06
Profitability
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROCE 14.62%
ROIC 12.94%
ROICexc 15.9%
ROICexgc 66.94%
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
FCFM 23.8%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)7.24%
ROIC(5y)7.33%
ROICexc(3y)8.58%
ROICexc(5y)8.54%
ROICexgc(3y)38.33%
ROICexgc(5y)45.6%
ROCE(3y)8.18%
ROCE(5y)8.29%
ROICexgc growth 3Y18.32%
ROICexgc growth 5Y-5.98%
ROICexc growth 3Y44.94%
ROICexc growth 5Y7.84%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
F-Score9
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Debt/EBITDA 0.83
Cap/Depr 71.61%
Cap/Sales 5.8%
Interest Coverage 15.71
Cash Conversion 86.85%
Profit Quality 118.23%
Current Ratio 1.38
Quick Ratio 1.04
Altman-Z 5.61
F-Score9
WACC8.03%
ROIC/WACC1.61
Cap/Depr(3y)55.86%
Cap/Depr(5y)76.64%
Cap/Sales(3y)5.68%
Cap/Sales(5y)6.46%
Profit Quality(3y)111.45%
Profit Quality(5y)122.7%
High Growth Momentum
Growth
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
EPS Next Y2.96%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
EPS Next 5Y16.75%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%
Revenue Next Year11.84%
Revenue Next 2Y12.38%
Revenue Next 3Y12.24%
Revenue Next 5Y10.92%
EBIT growth 1Y40.24%
EBIT growth 3Y42.99%
EBIT growth 5Y12.61%
EBIT Next Year62.5%
EBIT Next 3Y32.86%
EBIT Next 5Y25.36%
FCF growth 1Y100.22%
FCF growth 3Y35.04%
FCF growth 5Y20.27%
OCF growth 1Y84.46%
OCF growth 3Y26.98%
OCF growth 5Y16.21%

UCB SA / UCB.BR Fundamental Analysis FAQ

What is the fundamental rating for UCB stock?

ChartMill assigns a fundamental rating of 6 / 10 to UCB.BR.


Can you provide the valuation status for UCB SA?

ChartMill assigns a valuation rating of 3 / 10 to UCB SA (UCB.BR). This can be considered as Overvalued.


Can you provide the profitability details for UCB SA?

UCB SA (UCB.BR) has a profitability rating of 7 / 10.


What are the PE and PB ratios of UCB SA (UCB.BR) stock?

The Price/Earnings (PE) ratio for UCB SA (UCB.BR) is 25 and the Price/Book (PB) ratio is 4.47.


What is the earnings growth outlook for UCB SA?

The Earnings per Share (EPS) of UCB SA (UCB.BR) is expected to grow by 2.96% in the next year.